The surgery was performed as part of an early-stage clinical trial to evaluate its safety and
AuriNovo is an implant developed by 3DBio Therapeutics. The operation was led by Arturo Bonilla, founder and director of the Microtia Institute.
First, the patient had a 3D scan of the opposite ear to create a blueprint. The researchers then took a sample of ear cartilage cells to grow it.
These cells were then mixed with bioink forcollagen base to artificially form the outer ear. The implant was surrounded by a printed, biodegradable shell to maintain its shape. Later, it is absorbed into the patient's body.
According to the researchers, the implanted ear matures over time, acquires a natural appearance and feels like a normal ear.
It is expected that 11 patients will take part in the clinical study.
Read more
Diagnosis in a minute: how IT is changing healthcare
Chinese AI predicts the course of hypersonic missiles. The retaliatory strike will be ahead
Scientists have found the largest plant: its length is 180 km, and its age is about 4.5 thousand years